BRIDGEWAY CAPITAL MANAGEMENT, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$986,000
+6.2%
402,300
+76.4%
0.02%
+11.8%
Q2 2021$928,000
-20.3%
228,000
-11.6%
0.02%
-22.7%
Q1 2021$1,164,000
+58.8%
258,000
+73.2%
0.02%
+46.7%
Q4 2020$733,000
-43.3%
149,000
-31.7%
0.02%
-50.0%
Q3 2020$1,293,000
+122.9%
218,0000.0%0.03%
+150.0%
Q2 2020$580,000
+152.2%
218,000
+84.7%
0.01%
+140.0%
Q1 2020$230,000118,0000.01%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders